Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Epilepsy Elderly Article
This is a selection made from among articles on Drug Treatment Epilepsy Elderly. For a permanent link to this article, or to bookmark it for future reading, click here.
Arizona Drug Rehab Finding Help in Arizona
from:
The state of Arizona has one of the worst drug problems in the United States. Historically and currently, the state is known as a transhipment location for a variety of drugs, including heroin, cocaine and marijuana, which are imported from other countries. As a result, these and other drugs are widely available in the state, and their abuse is common. There are probably few states that require the presence of rehabilitation centers as this one does - thankfully Arizona drug rehab centers are some of the best in the world.
There is a wide range of treatment centers in Arizona that employ a range of different techniques to help the patient break their addiction. Some of these will have particular specialisations, which might be more appropriate for certain types of patient, so it is always sensible to find out as much as you can about an Arizona drug rehab before making an appointment. Services like drugs-rehabs.org will be able to provide you with treatment center listings in your area, with basic descriptive information to help you make the best decision for you. Some of the features that might help influence your decision for the best:
· Does the center have a particular religious affiliation? While Christian centers, for example, might be willing to accept non-Christian patients, many will feel more comfortable in a non-denominational center, or one that practises their own faith.
· What type of care is available? Ensure that your chosen center has a program specifically for drug detoxification. Other kinds of therapy will be useful, but it will be necessary for the patient to make a commitment to ceasing drug use also.
· What facilities are available? Some Arizona drug rehab centers will only cater to outpatients, which may not offer enough support to a badly addicted patient. Find a center that provides inpatient care.
· What payments options are available? Does the center accept Medicare, Medicaid or private health insurance? If you are not involved with any of these programs, can your center offer sliding scale payments?
There are many high quality Arizona drug rehab treatment centers available, but it is important that you choose the best one for you or your loved one. Never hesitate to contact a center directly to find out more about their facilities, or to find out whether they can cater to any special needs you might have. The right treatment center is out there, and with a little investment of time and effort, you will find it. The best treatment for you or your loved one will be well worth it.
About Author
Jeff Lakie is the founder of Rehab Resources a website providing information on drug and alcohol rehabilitaiton treatments
Source: ArticleTrader.com
Drug Treatment Epilepsy Elderly Specific links
Drug Treatment Epilepsy Elderly News
Biowatch: Supernus debuts on the Nasdaq, awaits ruling on epilepsy drugs - Gazette.Net: Maryland Community News Online
Biowatch: Supernus debuts on the Nasdaq, awaits ruling on epilepsy drugs Gazette.Net: Maryland Community News Online by Gazette Staff Supernus Pharmaceuticals, the Rockville biotech that's developing drugs to treat epilepsy, depression and attention deficit hyperactivity disorder, got off to a solid start in its first week of trading as a public company. |
Abbott to Pay $1.6 Billion to Settle Depakote Drug Allegations - BusinessWeek
 USA TODAY | Abbott to Pay $1.6 Billion to Settle Depakote Drug Allegations BusinessWeek By Jef Feeley and Margaret Cronin Fisk on May 08, 2012 Abbott Laboratories (ABT) (ABT) said it reached an agreement to pay $1.6 billion to settle federal and state claims resulting from an investigation into its epilepsy medication Depakote, ... Abbott Laboratories agrees to $1.6 billion settlement over marketing of Depakote Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion ... Kentucky, others settle with Abbott |
Abbott Laboratories to pay $1.6 billion over misbranding drug - CNN International
USA TODAY | Abbott Laboratories to pay $1.6 billion over misbranding drug CNN International Abbott pleaded guilty to misbranding Depakote by promoting the drug to control agitation and aggression in patients with elderly dementia and to treat schizophrenia when neither use was approved by the Food and Drug Administration, ... Abbott To Pay $1.6B To Settle Depakote Marketing Probes Abbott to Pay $1.5 Billion for Unlawfully Promoting a Drug Posted: May 7, 2012 - 2:30 pm ET |
Abbott To Pay $1.6B To Settle Depakote Marketing Probes - Wall Street Journal
 BBC News | Abbott To Pay $1.6B To Settle Depakote Marketing Probes Wall Street Journal Neither of those so-called off-label uses were approved by the Food and Drug Administration. The drug is approved to treat epilepsy and bipolar disorder and to prevent migraines. Drug makers are generally barred from actively promoting such off-label ... Abbott to Pay $1.5B for Off-Label Promotion of Depakote Drugmaker Abbott Laboratories pleads guilty to illegal marketing Abbott Labs Settles Depakote Lawsuits for $1.6B |
Caring for England's poorest patients: Liverpool GP who welcomes all-comers - The Guardian
 The Guardian | Caring for England's poorest patients: Liverpool GP who welcomes all-comers The Guardian I had epilepsy and [drugs] was … well, you know, drugs was a way out," says Foran. "In the end I had to give up. I was thinking about family and settling down. You got to admit it to yourself." Acknowledging his addiction in his own mind was the first ... |
Big Bitter Pill for Big Drug Maker - About - News & Issues
Big Bitter Pill for Big Drug Maker About - News & Issues Abbott also confessed that from 2001 through 2006, it had illegally marketed Depakote as a supplemental treatment for schizophrenia. The FDA has approved Depakote only for treatment of epileptic seizures, bipolar mania, and for the prevention of ... Abbott Labs to Pay $1.5 Billion for Unapproved Marketing Abbott Labs reaches agreements over medicine |
New Lyrica Oral Formulation For Patients With Dysphagia Available In UK - Medical News Today
New Lyrica Oral Formulation For Patients With Dysphagia Available In UK Medical News Today Pregabalin is licensed to treat peripheral and central neuropathic pain, generalized anxiety disorder (GAD) in adults as well as an adjunctive therapy for partial seizures with or without secondary generalization in adults. "By bringing pregabalin oral ... |
Business Week Article States That Manufacturer of Depakote Agrees to Pay $1.6 ... - San Francisco Chronicle (press release)
Business Week Article States That Manufacturer of Depakote Agrees to Pay $1.6 ... San Francisco Chronicle (press release) The investigation was ongoing because Depakote was approved for use for treatment of symptoms of conditions that include epilepsy, migraine headaches and the symptoms associated with the manic episodes of bipolar disorder, but Abbott Laboratories ... |
Medicinal claims all smoke - Worcester Telegram
Medicinal claims all smoke Worcester Telegram They claim that marijuana is useful for treating cancer, epilepsy, anorexia and wasting syndromes commonly associated with HIV/AIDS. They also claim it helps with multiple sclerosis and spinal-cord injuries, muscle spasms, bladder dysfunction, ... |
Reducing Brain Activity Improves Memory in Amnestic Mild Cognitive Impairment - SeniorJournal.com
 SeniorJournal.com | Reducing Brain Activity Improves Memory in Amnestic Mild Cognitive Impairment SeniorJournal.com The researchers used a low dose of a drug used clinically to treat epilepsy, for the purpose of reducing hippocampal activity in subjects with aMCI to levels that were similar to activity levels in healthy, age-matched subjects in a control group. |